ForteBio Repositioned to Focus on Delivering Breakthroughs in Early Stage Biologic Drug Development
Molecular Devices announces brand identity for its newly-formed biologics business unit
Molecular Devices announces brand identity for its newly-formed biologics business unit
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy
Scientists to present research demonstrating the use of Bio-Rad’s Droplet Digital technology for highly accurate copy number quantification, mutation detection, and single-cell sequencing.
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Learn how a cutting-edge tool is being used by drug development scientists to optimize preclinical studies
Scientists discuss the speed, reproducibility, and versatility of the Countstar Mira cell counting range
Ribbon Bio Co-founder, Wladimir Labeikovsky, provides unique perspectives on synthetic DNA and discusses the company’s commitment to producing pure and accurate synthetic DNA molecules
Learn how organ-on-a-chip technology is aiding toxicologists in de-risking drug-induced liver injury by providing human-specific safety data
This article tells the story of Target Malaria, a project that is fighting malaria with genetically modified mosquitoes
Increasing speed and sensitivity with 2D-LC